Chemical | 18 February 2021
Lupin launches posaconazole delayed-release tablets
posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.
posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.
EBITDA excluding non-recurring items amounted to SEK 257 m (275).
Revenue of $783 million increased 13 percent compared to $693 million.
.jpg)
Decreased custom duty on naphtha is likely to further improve the utilization of crackers resulting in availability of cost competitive olefins and aromatics.
Responding to a media report ‘Clariant Chemicals to buy 51% in India Glycols' specialty chemical biz’, India Glycols stated that the company is yet to take any final decision regarding any collaboration.
The Profit before exceptional item & tax stood at Rs. 19.0 crore for the quarter ended December 31, 2020.
Net debt for the total Group decreased to CHF 1.040 billion versus CHF 1.372 billion recorded at the end of 2019.
India business grew 11.8% YoY vs mid-single digit industry growth.
The aim of this transfer and consolidation is to increase the operational efficiency of the membrane business
OQ Chemicals is monitoring this Force Majeure event and is working diligently to resume production as soon as possible.
It currently has registrations and licenses for 22 agro-chemical Technicals and 124 formulations for sale in India and 27 agro chemical Technicals and 34 formulations for exports purpose.
Dimethyl Formamide (DMF) saw strong demand and price surge owing to the short-supply situation in countries (China and Saudi Arabia) that export to India.
The company posted net profit of Rs.1.68 crores for the period ended December 31, 2019.
The company has posted net lossof Rs. 4.08 crores for the period ended December 31, 2019.
The company posted net profit of Rs.8.07 crores for the period ended December 31, 2019.
Chemical companies invested in IT infrastructure, which helped them save operating and administration costs.
The increase in revenues in polyurethanes segment was primarily due to higher MDI average selling prices.
The company posted net profit of Rs.137.9 crores for the period ended December 31, 2019.
The company posted net loss of Rs. 3.80 crores for the period ended December 31, 2019.
The company posted net profit of Rs.8.01 crores for the period ended December 31, 2019.
Subscribe to our newsletter & stay updated.
